Bristol-Myers Squibb Sues Apotex

November 29, 2011

Bristol-Myers Squibb filed suit against Apotex over four patents related to cyclic protein tyrosine kinase inhibitors.  11/23, District of New Jersey, 3:2011cv06918.

Access to the full article is currently available to RPX members only. Please contact us if you need further information.

Related News